Clinical fellowship applicants must hold an MD degree or equivalent, and be within five years of completion of specialization OR in training to achieve such specialization (e.g. Fellow, Resident, Registrar, etc.).
Research fellowship applicants may hold either an MD or PhD degree and must be within five years of training completion.
All applicants should have a demonstrated interest in psoriasis.
Research Track Details:
Research fellows will be matched with clinical, translational, or laboratory-based psoriasis research mentors. Fellows are expected to observe and contribute to an active study or co-develop a small-scale research project with their mentor. The program emphasizes flexibility, relationship-building, and foundational research skill development as well as active interaction between research and clinical care to foster long-term collaborations. The on-site visit will last up to 12 weeks, and financial support will be $1,100 per week.
Clinical Track Details:
Clinical fellows will be matched with mentors primarily involved in clinical practice and patient care. Fellows are expected to observe and develop their patient treatment skills. The program emphasizes clinical practice learning and skill development as well as active interaction between clinical care and research. The on-site visit will be for a minimum of two weeks up to four weeks, and financial support will be $1,100 per week.
Both the Research and Clinical Fellowships include:
In-person and Virtual Mentoring
Congress attendance
Other
Awarded fellows receive a stipend to cover the following expenses:
For questions about the IPC International Fellowship Program, please send an email to Fellowship@psoriasiscouncil.org.
SPECIAL NOTE: If AI is used to assist in writing the Personal Statement, ensure it has been adequately reviewed before submission. In addition to covering the points above, it should reflect the applicant’s enthusiasm for developing their skills in psoriasis and reflect the applicant’s unique voice and perspective.
SPECIAL NOTE: Please do not submit a general letter of recommendation. Letters should be written by someone who knows the applicant personally and can specifically speak to their interest in psoriasis, as well as their suitability for this fellowship opportunity.
WORKING TOWARDS CONTINUAL PROGRAM IMPROVEMENT IN THE BEST INTERESTS OF THE PAST, PRESENT AND FUTURE IPC INTERNATIONAL FELLOWS
The IPC International Fellowship Program Advisory Committee is comprised of IPC Board Members, Councilors, and Junior Councilors who work to ensure that the further development of IPC’s Fellowship program is in keeping with and in support of IPC’s strategic plan in partnership with the executive team. Together they review, analyze, and generate new ideas to work towards continual program improvement in the best interests of the past, present and future IPC International Fellows.
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
